Agios Pharmaceuticals
(NASDAQ) AGIO
Agios Pharmaceuticals Financials at a Glance
Market Cap
$1.60B
Revenue (TTM)
$66.05M
Net Income (TTM)
$422.60M
EPS (TTM)
$-7.25
P/E Ratio
-3.72
Dividend
$0.00
Beta (Volatility)
1.24 (Average)
Dividend
$0.00
Beta (Volatility)
1.24 (Average)
Price
$27.53
Volume
722,509.764
Open
$27.20
Price
$27.53
Volume
722,509.764
Open
$27.20
Previous Close
$27.53
Daily Range
$26.94 - $27.57
52-Week Range
$22.24 - $46.00
Dividend
$0.00
Beta (Volatility)
1.24 (Average)
Price
$27.53
Volume
722,509.764
Open
$27.20
Previous Close
$27.53
Daily Range
$26.94 - $27.57
52-Week Range
$22.24 - $46.00
AGIO News
AGIO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Agios Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
540
CEO
Brian M. Goff, MBA
Website
www.agios.comHeadquarters
Cambridge, MA 02139-4169, US
AGIO Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
-7%
Net Income Margin
-6%
Return on Equity
-33%
Return on Capital
-42%
Return on Assets
-36%
Earnings Yield
-26.88%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.60B
Shares Outstanding
59.47M
Volume
722.51K
Avg. Volume
1.07M
Financials (TTM)
Gross Profit
$42.51M
Operating Income
$472.13M
EBITDA
$466.95M
Operating Cash Flow
$372.98M
Capital Expenditure
$4.32M
Free Cash Flow
$377.29M
Cash & ST Invst.
$854.42M
Total Debt
$62.02M
Agios Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$20.75M
+137.7%
Gross Profit
$18.06M
+183.9%
Gross Margin
87.07%
N/A
Market Cap
$1.60B
N/A
Market Cap/Employee
$3.30M
N/A
Employees
486
N/A
Net Income
$99.11M
-11.0%
EBITDA
$108.66M
-3.1%
Quarterly Fundamentals
Net Cash
$701.29M
-16.6%
Accounts Receivable
$16.13M
+382.4%
Inventory
$35.09M
+18.5%
Long Term Debt
$16.94M
-52.6%
Short Term Debt
$18.80M
+9.4%
Return on Assets
-35.66%
N/A
Return on Invested Capital
-42.23%
N/A
Free Cash Flow
$119.69M
-6.6%
Operating Cash Flow
$118.92M
-6.7%